UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 10, 2021
Accession Number:
Submission Type:
CIK: 0000109657
Company Name: GT Biopharma, Inc.
File Number: 333-251311